Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02815995
Title Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

hemangioma

leiomyosarcoma

synovial sarcoma

lipoma

osteosarcoma

angiosarcoma

sarcoma

Therapies

Durvalumab + Tremelimumab

Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.